Market Overview
| Study Period | 2019 - 2030 |
|---|---|
| Base Year For Estimation | 2024 |
| Forecast Data Period | 2025 - 2030 |
| Market Size (2025) | USD 5.14 Billion |
| Market Size (2030) | USD 7.81 Billion |
| Growth Rate (2025 - 2030) | 8.72% CAGR |
| Market Concentration | Medium |
Major Players
*Disclaimer: Major Players sorted in no particular order Image © Mordor Intelligence. Reuse requires attribution under CC BY 4.0. |
|
India Pharmaceutical Packaging Market Analysis by Mordor Intelligence
India pharmaceutical packaging market size stood at USD 5.14 billion in 2025 and is projected to reach USD 7.81 billion by 2030, advancing at an 8.72% CAGR over the forecast period. Heightened demand emerges from production-linked incentive outlays, digital therapeutics adoption, and rigorous sustainability regulations. Capacity additions at export-oriented plants are boosting uptake of good-manufacturing-practice compliant containers and closures, while e-pharmacy growth accelerates orders for tamper-evident flexible packs. Sustainability mandates compelling 30% recycled content in rigid formats are shaping material choices, with recycled polyethylene terephthalate and post-consumer-recycled resins gaining validation. Simultaneously, biologics fill-finish expansion encourages cold-chain compatible vials, syringes, and high-barrier films, and ongoing polymer price volatility is prompting converters to streamline sourcing and adopt digital cost controls.
Key Report Takeaways
- By material type, primary packaging held 60.23% of the India pharmaceutical packaging market share in 2024 and is forecast to grow at a 9.21% CAGR through 2030.
- By product type, plastics remained dominant with 41.32% 2024 revenue share, although composites and bio-based resins recorded 10.21% CAGR 2030, the fastest among all materials.
- By packaging level, bottles led with 21.43% contribution in 2024, while pouches and bags posted the strongest 9.54% CAGR 2030 among products.
- By end-user industry, pharmaceutical manufacturers retained the largest 49.98% 2024 end-user share during and contract packaging organizations expanded at a 10.11% CAGR 2030 .
- By gujarat accounted for roughly one-third of national drug output in 2024, underpinning clustering benefits for converters and logistics efficiencies.
India Pharmaceutical Packaging Market Trends and Insights
Drivers Impact Analysis
| Driver | (~) % Impact on CAGR Forecast | Geographic Relevance | Impact Timeline |
|---|---|---|---|
| Accelerated shift to pre-fillable formats | +1.8% | Gujarat, Maharashtra | Medium term (2-4 years) |
| Expansion of India's vaccine and biologics fill-finish capacity | +2.1% | Major pharma hubs nationwide | Long term (≥ 4 years) |
| Government PLI and GMP upgrades for export-oriented pharma | +2.3% | SEZ and export zones | Medium term (2-4 years) |
| E-pharmacy boom driving tamper-evident, home-delivery packs | +1.6% | Urban centers, Tier-2 rollout | Short term (≤ 2 years) |
| Sustainability mandates pushing rPET and PCR rigid plastics | +1.2% | Metro areas, national scope | Long term (≥ 4 years) |
| Source: Mordor Intelligence | |||
Expansion of India's Vaccine and Biologics Fill-Finish Capacity
India’s ambition to become a global biologics hub is fueling specialized containment demand. Ongoing investments, including Lonza’s gelatin capsule line in Rewari, require high-barrier films that withstand sterilization and maintain sub-zero stability across extended logistics chains. Growth in cold-chain packaging with integrated temperature indicators is enabling uninterrupted product integrity from plant to patient. Biologic developers also favor tamper-evident seals and unit-level serialization for supply chain visibility, encouraging converters to scale ISO-8 clean-room production.
Government PLI and GMP Upgrades for Export-Oriented Pharma
The Production-Linked Incentive scheme earmarked INR 2,444.93 crore (USD 293 million) for FY 2025-26, driving systematic upgrades in packaging infrastructure and supporting simultaneous compliance with FDA 21 CFR 211.132 and EU FMD serialisation requirements. Subsidy applicants must meet ambitious export targets, which translate into orders for premium laminated foils, tamper-proof closures, and cloud-connected vision inspection units. The December 2025 GMP upgrade deadline compels facilities to install ISO-8 compatible lines, raising recurring demand for validated primary packs and cleanroom consumables.
E-Pharmacy Boom Driving Tamper-Evident, Home-Delivery Packs
Direct-to-consumer medicine delivery grew swiftly across metropolitan markets, with mobile apps integrating AI dosage reminders. Packages must endure multiple courier handoffs and still assure authenticity, prompting the adoption of serialized QR-codes and break-away seals.[1]Elisabeth Cuneo, “Three Trends Shaping Pharmaceutical Packaging Today,” healthcarepackaging.com Flexible pouches sized for chronic-care regimens improve portability, and moisture-barrier sachets cater to personalized dosing. Automated dispensing warehouses favor stackable mailers that streamline pick-and-pack robotics, reinforcing demand for lightweight yet puncture-resistant laminates.
Sustainability Mandates Pushing rPET and PCR Rigid Plastics
Extended Producer Responsibility rules mandate 30% recycled content in 2024-25, escalating to 60% by 2027-28, compelling converters to validate recycled resins for pharmaceutical use. UFlex has commercialized a 90% PCR biaxially-oriented polyester film, demonstrating regulatory-approved recycled content in blister webs. Converters are investing in traceable waste-feedstock procurement and in-house pelletizing to guarantee supply continuity. Sustainable moves dovetail with brand differentiation as exporters preference carbon-reduced packs for regulated markets.
Restraints Impact Analysis
| Restraint | (~) % Impact on CAGR Forecast | Geographic Relevance | Impact Timeline |
|---|---|---|---|
| Volatility in medical-grade polymer and glass input costs | -1.4% | Import-dependent regions | Short term (≤ 2 years) |
| Single-use-plastic EPR and recycling logistics gaps | -0.9% | Tier-2/3 cities | Medium term (2-4 years) |
| High cap-ex for ISO-8 clean-room packaging lines | -1.1% | Gujarat, Maharashtra, Tamil Nadu | Long term (≥ 4 years) |
| Fragmented downstream distribution inflating unit pack costs | -0.8% | Rural networks in rural distribution networks | Medium term (2-4 years) |
| Source: Mordor Intelligence | |||
Volatility in Medical-Grade Polymer and Glass Input Costs
Polypropylene fluctuated between USD 970-990 per metric ton CFR India in 2025, eroding converter margins and complicating contract pricing. Glass container makers face rising energy tariffs and silica sand shortages, adding pass-through costs for high-value vials. Overall EBITDA margins for flexible packaging dipped to 8% in FY 2024-25 amid resin oversupply and lukewarm export demand. These factors force packaging firms to hedge raw materials and optimize formulations to cushion profitability.
Single-Use-Plastic EPR and Recycling Logistics Gaps
While mandatory recycled-content thresholds are clear, collection infrastructure for contaminated pharmaceutical plastics lags, particularly beyond primary cities. Separate handling protocols and traceability requirements inflate reverse-logistics expenses, and uneven state-level enforcement breeds compliance uncertainty. Producers are piloting take-back programs, yet commercial scale remains limited, constraining availability of pharmaceutical-grade PCR feedstock and delaying broader circular-economy benefits.
Segment Analysis
By Material Type: Sustainable Alternatives Gain Momentum
In 2024, plastics led with 41.32% revenue, yet composites and bio-based resins surged at a 10.21% CAGR, the highest among all materials. Stringent Extended Producer Responsibility norms are spurring trials of recycled PET inserts and sugarcane-based HDPE lines. Pharmaceutical buyers insist on full extractable-leachable validation, prompting converters to build application labs and secure regulatory master files. India's pharmaceutical packaging market size for bio-based materials is set to expand quickly as contract packers market greener credentials to multinational sponsors. Parallel investments in enzymatic delamination promise recovery of aluminum layers from aseptic cartons, illustrating innovation depth. Future growth depends on a robust supply chain for high-purity recycled feedstock and harmonized national testing standards.
Sustainability themes also reshape glass and metal demand. Borosilicate vials retain relevance for biologics owing to inertness, yet lightweight coated glass variants target energy reductions during melt. Aluminum collapsible tubes find use in topical formulations where zero-leach barriers and recyclability offer dual appeal. Paperboard is regaining favor for secondary cartons as water-based coatings achieve 95% humidity resistance, satisfying patient safety while enabling fiber recovery. Collectively these shifts reflect heightened material stewardship across the India pharmaceutical packaging market.
Note: Segment shares of all individual segments available upon report purchase
Get Detailed Market Forecasts at the Most Granular Levels
Download PDF
By Product Type: Flexible Formats Drive Innovation
Bottles commanded 21.43% of 2024 revenue, yet pouches and bags logged a 9.54% CAGR, the fastest among all categories, fueled by e-pharmacy parcel shipping. India's pharmaceutical packaging market share for prefilled syringes is climbing as biologic therapies proliferate, demanding silicon-oil-free plungers and tight particulate controls. Meanwhile, blister-pack upgrades focus on child-resistant push-through lidding and NFC tags that connect patients to refill portals. Smart features migrate into flexible sachets, embedding humidity sensors for at-home adherence monitoring.
Downstream, rapid swab kits and nasal sprays push demand for snap-fit caps, integrated droppers, and low-dead-volume valves. Converters offering turnkey molding plus pulsed-light sterilization win contracts where lean supply chains are pivotal. India pharmaceutical packaging market size for adaptive closures is projected to widen as personalized therapy packs and micro-dosing devices multiply. The resulting SKU complexity rewards firms capable of short-run digital printing and agile changeovers.
By Packaging Level: Primary Packaging Dominance Continues
Primary formats captured 60.23% revenue in 2024, reflecting direct contact requirements that elevate regulatory scrutiny and capital intensity. Serialization imprints at the dose level improve anti-counterfeit control and allow remote batch recalls, aligning with National Drug Authentication plans. [2]Andrea Corona, “2025 Pharma Predictions,” pharmamanufacturing.comFuture primary pack trends center on built-in RFID for cold-chain visibility and laser-etched variable data replacing paper inserts. Secondary and tertiary packs, while smaller contributors, embrace recycled fiber content and right-sized cushioning to shrink deadweight in ecommerce parcels.
Multi-layer compatibility between primary vials, nested tubs, and shippers influences barrier design. High-density polyethylene blow-fill-seal bottles bring sterile barrier integrity and shorten validation cycles, attracting oral-liquid generics. India's pharmaceutical packaging market size, attributed to blow-fill-seal, will benefit from track-and-trace mandates at the bottle level. Automated vision cameras combined with AI detect 10 micron particulates, cutting inspection labor and elevating batch throughput for export-grade packing houses.
Note: Segment shares of all individual segments available upon report purchase
Get Detailed Market Forecasts at the Most Granular Levels
Download PDF
By End-User Industry: Contract Packaging Organizations Accelerate
Pharmaceutical manufacturers retained 49.98% 2024 spending, yet contract packaging organizations (CPOs) advanced at a 10.11% CAGR as innovators outsource non-core activities. CPOs leverage scale procurement and dedicated compliance teams to satisfy multi-jurisdiction audits, positioning themselves as growth engines within the India pharmaceutical packaging market. Many add formulation and analytic labs to become one-stop CDMOs, aligning with global sponsor preference for integrated supply chains.
Retail and institutional pharmacies now favor shelf-ready packs featuring scannable lids and recyclable trays that speed dispensing. Hospital demand for ready-to-administer injector cartridges spurs CPO investment in barrier isolators and high-speed plunger insertion. Meanwhile, healthcare startups seek tiny batch runs for orphan drugs, prompting contract packers to deploy modular lines that can switch between nested vials and pump sprays in under an hour. This agility cements CPOs as pivotal stakeholders through 2030.
Geography Analysis
Gujarat generated roughly one-third of national pharmaceutical output in 2024, reinforcing the state’s anchor role in the India pharmaceutical packaging market. Ports at Mundra and Pipavav enable swift resin imports and finished-pack exports, while a dense vendor base shortens lead times for ISO-certified tooling. State government incentives further entice converters to locate extrusion, printing, and sterilization units adjacent to large drug plants, compressing supply cycles and lowering logistics carbon footprint.
Maharashtra and Tamil Nadu follow as regional focal points, particularly for complex biologics and hormone therapies that demand clean-room vial washing and cold-storage warehouses. Recent industrial parks near Pune and Chennai integrate common effluent treatment and centralized utility corridors, easing GMP compliance for packaging producers. India pharmaceutical packaging market size, attributed to southern clusters, grows as multinational sponsors award long-term fill-finish projects conditioned on proximity to international airports.
Emerging northeastern corridors benefit from freight subsidies yet grapple with container shortages and limited specialty-film supply. Converters establishing satellite depots in Assam and Meghalaya gain first-mover advantage but must invest in on-site quality testing and redundant power to assure consistency. National highway upgrades under Bharatmala Phase-I unlock road transit to northern drug depots, balancing distribution across hinterlands and positioning the India pharmaceutical packaging market for broader geographic diversification.
Competitive Landscape
The competitive field features multinational specialists, diversified Indian conglomerates, and nimble regional firms, creating a moderately fragmented structure. No single company exceeds a 15% revenue share across the India pharmaceutical packaging market, though some dominate niches such as polymer films or glass ampoules. Technology differentiation, particularly in digital serialization and in-line vision systems, is the chief contract-winning lever; converters with proven data-integrity frameworks and cyber-secure cloud dashboards gain insurer and regulator confidence.
UFlex extends vertical reach from PET resin extrusion to finished blister foils, leveraging in-house ink and coating chemistries that accelerate custom barrier solutions.[3]UFlex Limited, “UFlex News and Insights,” uflexltd.com Gerresheimer’s acquisition of Bormioli Pharma strengthens glass vial capacity, giving global vaccine makers dual-source risk mitigation. Domestic newcomer Mold-Tek Packaging deploys in-mold labeling for high-definition graphics, lowering copy-cat risk for over-the-counter brands. Polymerupdate-reported raw material swings push converters to secure long-term resin contracts, leading some to consider backward integration into polypropylene compounding.
White-space opportunities revolve around smart packaging, with start-ups embedding NFC chips in child-safe caps for dose reminders. Sustainability continues as a battleground: firms first-certified for 60% PCR rigid bottles are likely to lock in supply agreements with multinational generic majors looking to meet EU Green Deal provisions. Collaborations with cloud analytics vendors to create predictive maintenance for form-fill-seal lines illustrate the convergence of packaging and Industry 4.0, sharpening the competitive divide between digital leaders and laggards.
India Pharmaceutical Packaging Industry Leaders
-
Medipack Innovations Private Limited
-
N S Industries
-
A S Packers
-
North East Pharmapack Pvt Ltd
-
Packtime Innovations Pvt Ltd
- *Disclaimer: Major Players sorted in no particular order
Need More Details on Market Players and Competitors?
Download PDF
Recent Industry Developments
- September 2025: Mankind Pharma partnered with OpenAI to deploy predictive AI quality analytics across packaging and distribution workflows, targeting batch-release cycle reductions.
- March 2025: ONGC subsidiary OPaL exited Dahej SEZ to operate as a Domestic Tariff Area unit, enabling direct polypropylene sales to local converters and easing polymer availability.
- January 2025: UFlex showcased UV LED inks and 90% PCR BOPET film at PrintPack 2025, underlining momentum toward sustainable high-barrier laminates.
- December 2024: Gerresheimer closed the acquisition of Bormioli Pharma, bolstering borosilicate vial and cartridge supply for India-centric biologics exporters.
India Pharmaceutical Packaging Market Report Scope
Pharmaceutical packaging is the packaging process for pharmaceutical products. The packaging material can be of several raw materials, such as glass and plastic, and its application depends on the reactivity of the pharmaceutical products to be packaged. The report provides a granular view of the pharmaceutical packaging industry in India with a breakdown of segments by product type and material type. The market is defined by the revenue accrued from the sales of different pharmaceutical packaging products offered by various vendors operating in the market.
The Indian pharmaceutical packaging market is segmented by material type (plastic, glass, and other material types) and product type (bottles, vials and ampoules, syringes, tubes, caps and closures, pouches and bags, labels, and other product types). The market sizes and forecasts are provided in terms of value (USD) for all the above segments.
By Material Type
| Plastic | High-Density Polyethylene (HDPE) |
| Low-Density Polyethylene (LDPE) | |
| Polyethylene Terephthalate (PET) | |
| Other Plastics | |
| Glass | |
| Metal | |
| Paper and Paperboard | |
| Composites/ Bio-based Materials |
By Product Type
| Bottles |
| Vials and Ampoules |
| Blister Packs |
| Prefilled Syringes and Cartridges |
| Tubes |
| Caps and Closures |
| Pouches and Bags |
| Labels |
| Other Product Types |
By Packaging Level
| Primary |
| Secondary |
| Tertiary |
By End-user Industry
| Pharmaceutical Manufacturing Companies |
| Contract Packaging Organizations |
| Retail and Institutional Pharmacies |
| Hospitals and Clinics |
| Other End-user Industries |
| By Material Type | Plastic | High-Density Polyethylene (HDPE) |
| Low-Density Polyethylene (LDPE) | ||
| Polyethylene Terephthalate (PET) | ||
| Other Plastics | ||
| Glass | ||
| Metal | ||
| Paper and Paperboard | ||
| Composites/ Bio-based Materials | ||
| By Product Type | Bottles | |
| Vials and Ampoules | ||
| Blister Packs | ||
| Prefilled Syringes and Cartridges | ||
| Tubes | ||
| Caps and Closures | ||
| Pouches and Bags | ||
| Labels | ||
| Other Product Types | ||
| By Packaging Level | Primary | |
| Secondary | ||
| Tertiary | ||
| By End-user Industry | Pharmaceutical Manufacturing Companies | |
| Contract Packaging Organizations | ||
| Retail and Institutional Pharmacies | ||
| Hospitals and Clinics | ||
| Other End-user Industries |
Need A Different Region or Segment?
Customize Now
Key Questions Answered in the Report
What value will pharmaceutical packaging in India reach by 2030?
It is projected to touch USD 7.81 billion by 2030, rising from USD 5.14 billion in 2025.
Which packaging level contributes the most revenue in India?
Primary formats account for 60.23% of 2024 revenue thanks to direct drug-contact requirements and serialisation rules.
Why are contract packaging organizations gaining share?
Pharmaceutical firms are outsourcing to specialized CPOs that offer compliance expertise and flexible capacity, leading to a 10.11% CAGR for the segment.
How are sustainability mandates influencing material choices?
Extended Producer Responsibility rules require 30% recycled content now and 60% by 2027-28, spurring adoption of PCR rigid bottles and recycled PET films.
Which Indian state is the primary hub for pharmaceutical packaging?
Gujarat hosts roughly one-third of national drug output and anchors a dense cluster of packaging suppliers, aided by deep-sea ports and policy incentives.
Page last updated on:
